Utpal Koppikar - 16 Mar 2022 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
16 Mar 2022
Net transactions value
$0
Form type
4
Filing time
17 Mar 2022, 16:20:49 UTC
Previous filing
03 Mar 2022
Next filing
19 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Award $0 +41,200 $0.000000 41,200 16 Mar 2022 Common Stock 41,200 $22.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33% of the shares underlying this option shall vest and become exercisable on March 16, 2023, with the remainder vesting in eight equal quarterly installments thereafter.